XML 46 R35.htm IDEA: XBRL DOCUMENT v3.25.3
COMMON STOCK PURCHASE WARRANTS (Tables)
9 Months Ended
Sep. 30, 2025
Common Stock Purchase Warrants  
SCHEDULE OF WARRANT ACTIVITY

The following table summarizes information about shares issuable under warrants outstanding during the nine months ended September 30, 2025 and 2024:

 

   Warrants  

Weighted

average
exercise price

 
Balance, January 1, 2025   5,448   $1,900.00 
Issuance February 2025 – Prefunded Warrants   49,075    0.001 
Issuance/activation of February 2025 – Series A Warrants   347,796    62.00 
Issuance of September 2025 – Detachable Warrants   476,569    2.124 
Issuance/activation of February 2025 – Series B Warrants   1,669,357     
Exercise February 2025 – Prefunded Warrants   (49,075)   0.001 
Exercised June 2024 - Series B warrants   (1,897)   0.001 
Exercised February 2025 – Series B Warrants   (1,669,320)    
Terminated/Cancelled        
Balance, September 30, 2025   827,953   $171.22 

 

   Warrants  

Weighted

average
exercise price

 
Balance, January 1, 2024   563   $13,000.00 
Issued   884    5,020.00 
Exercised        
Terminated/Cancelled        
Balance, September 30, 2024   1,447   $8,120.00 
SCHEDULE OF RANGE OF EXERCISE PRICES AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF WARRANTS

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase shares of Common Stock as of September 30, 2025:

 

    Outstanding and exercisable warrants 
Exercise price   Number of warrants  

Weighted average
remaining
contractual life

 
$    37    2.1 years 
$2.124    476,569    5.0 years 
$62.00    347,796    4.6 years 
$1,004.00    2,989    3.7 years 
$11,000,00    188    2.5 years 
$13,000.00    188    2.5 years 
$15,000.00    186    2.5 years 
             
      827,953    4.8 years 
SCHEDULE OF WARRANT MODIFICATION

 

   Pre funded warrants issuance date – February 13, 2025
assumptions
 
Volatility – range   110.1%
Risk-free rate   4.27%
Dividend   %
Remaining contractual term   0.03 years 
Exercise price  $0.001 
Common stock issuable under the warrants   49,075 
 
   Series A warrants issuance/activation date – May 6, 2025
assumptions
 
Volatility – range   158.07%
Risk-free rate   3.87%
Dividend   %
Remaining contractual term   5.0 years 
Exercise price  $62.00 
Common stock issuable under the warrants   347,796 
  
   Series A warrants transition date – June 27, 2025
assumptions
 
Volatility – range   154.71%
Risk-free rate   3.79%
Dividend   %
Remaining contractual term   4.86 years 
Exercise price  $62.00 
Common stock issuable under the warrants   347,796 
  
   Series B warrants issuance/activation date – May 6, 2025
assumptions
 
Volatility – range   195.04%
Risk-free rate   3.87%
Dividend   %
Remaining contractual term   2.5 years 
Exercise price  $0.00 
Common stock issuable under the warrants   1,669,357 
  
   Series B issuance date - December 17, 2024
assumptions
   Series B - December 31, 2024
assumptions
 
Volatility – range   105.5%   105.7%
Risk-free rate   4.26%   4.38%
Dividend   %   %
Remaining contractual term   4.5 years    4.48 years 
Exercise price  $0.001   $0.001 
Common stock issuable under the warrants   238,339    189,689 
  
   Issuance
date assumptions
   December 31, 2024
assumptions
   September 30, 2025
assumptions
 
Volatility – range   72.1 - 101.1%   105.7%   151.59%
Risk-free rate   4.255.46%   4.38%   3.68%
Dividend   %   %   %
Remaining contractual term   0.1-5.0 years    4.5 years    3.7 years 
Exercise price  $5,020.00   $1,004.00    1,004.00 
Common stock issuable under the warrants   884    2,989    2,989 
  
  

December 31, 2024

assumptions

  

September 30, 2025

assumptions

 
Volatility – range   109.5%   151.59%
Risk-free rate   4.38%   3.68%
Dividend   %   %
Remaining contractual term   3.3 years    2.5 years 
Exercise price   11,000.0015,000.00    11,000.0015,000.00  
Common stock issuable under the warrants   562    562